Feiteng Kong

450 total citations
18 papers, 260 citations indexed

About

Feiteng Kong is a scholar working on Surgery, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Feiteng Kong has authored 18 papers receiving a total of 260 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 7 papers in Pathology and Forensic Medicine and 7 papers in Oncology. Recurrent topics in Feiteng Kong's work include Vascular Malformations and Hemangiomas (14 papers), Tumors and Oncological Cases (7 papers) and Vascular Tumors and Angiosarcomas (6 papers). Feiteng Kong is often cited by papers focused on Vascular Malformations and Hemangiomas (14 papers), Tumors and Oncological Cases (7 papers) and Vascular Tumors and Angiosarcomas (6 papers). Feiteng Kong collaborates with scholars based in China, Canada and United Kingdom. Feiteng Kong's co-authors include Siyuan Chen, Yi Ji, Kaiying Yang, Xuepeng Zhang, Jiangyuan Zhou, Guoyan Lu, Bo Xiang, Tong Qiu, Xian Jiang and Yongbo Zhang and has published in prestigious journals such as Blood, International Journal of Cancer and Journal of the American Academy of Dermatology.

In The Last Decade

Feiteng Kong

17 papers receiving 256 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feiteng Kong China 9 217 71 56 42 42 18 260
Charlène E.U. Oduber Netherlands 8 246 1.1× 56 0.8× 67 1.2× 46 1.1× 44 1.0× 10 319
Jiangyuan Zhou China 11 268 1.2× 98 1.4× 86 1.5× 59 1.4× 55 1.3× 44 339
Kiersten Ricci United States 10 283 1.3× 94 1.3× 111 2.0× 75 1.8× 34 0.8× 24 324
E. Puzenat France 7 99 0.5× 31 0.4× 44 0.8× 74 1.8× 8 0.2× 19 187
Jenna L. Streicher United States 8 88 0.4× 25 0.4× 37 0.7× 44 1.0× 5 0.1× 19 174
M. Motamed United Kingdom 11 143 0.7× 62 0.9× 18 0.3× 31 0.7× 53 1.3× 15 341
Hanru Ying China 10 168 0.8× 55 0.8× 73 1.3× 45 1.1× 23 0.5× 22 258
Margitta Poetke Germany 6 169 0.8× 70 1.0× 73 1.3× 55 1.3× 9 0.2× 20 206
Erin Pinto United States 12 341 1.6× 150 2.1× 35 0.6× 13 0.3× 19 0.5× 22 475

Countries citing papers authored by Feiteng Kong

Since Specialization
Citations

This map shows the geographic impact of Feiteng Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feiteng Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feiteng Kong more than expected).

Fields of papers citing papers by Feiteng Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feiteng Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feiteng Kong. The network helps show where Feiteng Kong may publish in the future.

Co-authorship network of co-authors of Feiteng Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Feiteng Kong. A scholar is included among the top collaborators of Feiteng Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feiteng Kong. Feiteng Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zhou, Jiangyuan, Tong Qiu, Xue Gong, et al.. (2025). Efficacy and safety of high-vs low-dose sirolimus in patients with kaposiform hemangioendothelioma: A randomized clinical trial. Journal of the American Academy of Dermatology. 93(1). 124–131. 1 indexed citations
2.
Zhou, Jiangyuan, Min Yang, Tong Qiu, et al.. (2025). Long-Term Outcomes of Oral Propranolol for Facial Infantile Hemangioma. Plastic & Reconstructive Surgery. 157(1). 142–149.
3.
Yang, Min, T. Qiu, Jiangyuan Zhou, et al.. (2024). Clinical characteristics and managements of congenital hepatic hemangioma: a cohort study of 211 cases. Hepatology International. 19(3). 682–691. 1 indexed citations
4.
Qiu, Tong, Zixin Zhang, Jiangyuan Zhou, et al.. (2024). Clinical features of rapid involuting congenital hemangioma: A prospective study. Journal of the American Academy of Dermatology. 90(4). 870–872. 1 indexed citations
5.
Qiu, Tong, Yanan Li, Xue Gong, et al.. (2023). Oral antibiotic prophylaxis for infection in patients with vascular anomalies receiving sirolimus treatment: a multicenter retrospective study. Orphanet Journal of Rare Diseases. 18(1). 121–121. 5 indexed citations
6.
Zhou, Jiangyuan, Tong Qiu, Xue Gong, et al.. (2023). Impact of age and tumor size on the development of the Kasabach–Merritt phenomenon in patients with kaposiform hemangioendothelioma: a retrospective cohort study. Precision Clinical Medicine. 6(2). pbad008–pbad008. 2 indexed citations
7.
Zhou, Jiangyuan, Yanan Li, Tong Qiu, et al.. (2023). Long‐term outcomes of sirolimus treatment for kaposiform hemangioendothelioma: Continuing successes and ongoing challenges. International Journal of Cancer. 153(3). 600–608. 15 indexed citations
8.
Ji, Yi, Siyuan Chen, Jiangyuan Zhou, et al.. (2022). Sirolimus plus prednisolone vs sirolimus monotherapy for kaposiform hemangioendothelioma: a randomized clinical trial. Blood. 139(11). 1619–1630. 45 indexed citations
9.
Ji, Yi, Siyuan Chen, Kaiying Yang, et al.. (2021). A prospective multicenter study of sirolimus for complicated vascular anomalies. Journal of Vascular Surgery. 74(5). 1673–1681.e3. 37 indexed citations
10.
Ji, Yi, Kaiying Yang, Jiangyuan Zhou, et al.. (2021). Propranolol for the treatment of ulcerated infantile hemangiomas: A prospective study. Journal of the American Academy of Dermatology. 86(5). 1149–1151. 5 indexed citations
11.
Ji, Yi, Siyuan Chen, Kaiying Yang, et al.. (2021). Efficacy and Safety of Propranolol vs Atenolol in Infants With Problematic Infantile Hemangiomas. JAMA Otolaryngology–Head & Neck Surgery. 147(7). 599–599. 61 indexed citations
12.
Ji, Yi, Siyuan Chen, Kaiying Yang, et al.. (2020). Screening for infantile hepatic hemangioma in patients with cutaneous infantile hemangioma: A multicenter prospective study. Journal of the American Academy of Dermatology. 84(5). 1378–1384. 14 indexed citations
13.
Ji, Yi, Siyuan Chen, Jiangyuan Zhou, et al.. (2020). Chronic lymphedema in patients with kaposiform hemangioendothelioma: incidence, clinical features, risk factors and management. Orphanet Journal of Rare Diseases. 15(1). 313–313. 13 indexed citations
14.
Ji, Yi, Siyuan Chen, Lizhi Li, et al.. (2018). Kaposiform hemangioendothelioma without cutaneous involvement. Journal of Cancer Research and Clinical Oncology. 144(12). 2475–2484. 18 indexed citations
15.
Kong, Feiteng, et al.. (2015). Modified technique of bilateral gluteus maximus transposition for reconstruction of sphincter for pediatric traumatic fecal incontinence. Journal of Pediatric Surgery. 50(12). 2159–2163. 1 indexed citations
16.
Ji, Yi, Siyuan Chen, Lin Zhong, et al.. (2014). Fetus in fetu: two case reports and literature review. BMC Pediatrics. 14(1). 88–88. 31 indexed citations
17.
Kong, Feiteng, Fu‐Yu Li, Yongmei Chen, et al.. (2012). [Gluteus maximus transplantation for fecal incontinence after surgery of high anal atresia].. PubMed. 26(5). 571–5. 1 indexed citations
18.
Kong, Feiteng, et al.. (2010). Intussusception in infants younger than 3 months: a single center’s experience. World Journal of Pediatrics. 6(1). 55–59. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026